Vertex Pharmaceuticals has become the 33rd drugmaker to place 340B contract pharmacy restrictions, but the new policy exempts all six [...] …
Year: 2024
SPONSORED CONTENT
All entities who participate in the 340B program are subject to an Office of Pharmacy Affairs (OPA) audit regardless of entity type, size or volume of transactions. For the last five years, HRSA’s OPA has been completing approximately 200 audits a year and
…
An influential drug industry group and a major drugmaker each filed lawsuits challenging West Virginia’s 340B contract pharmacy access law [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker UCB recently told 340B providers in Arkansas that it will exempt them from its contract pharmacy restrictions. In a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Generic and biosimilar drugmaker Sandoz recently added a drug used in conjunction with cancer treatments to its list of drugs [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The federal office tasked with overseeing the 340B program will brief covered entities and manufacturers next week on the administrative [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
In last month’s column, I wrote about a reprehensible campaign by 340B opponents to tie this vital drug discount program [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Mississippi this week became the fourth state to face a legal challenge to its 340B contract pharmacy law, when the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A major national 340B provider advocacy group is condemning the newly introduced 340B ACCESS Act, arguing that the proposed overhaul [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Some long-time 340B advocates have warned that a new federal bill based on input from an alliance of the drug [...] …
